Minerva Neurosciences SG&A Expense (Quarterly) Insights

Minerva Neurosciences Inc (NERV)

2.37 +0.02 (+0.85%) USD | NASDAQ | May 03, 16:00

2.41 +0.04 (+1.69%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	2.451M
September 30, 2023	2.636M
June 30, 2023	2.632M
March 31, 2023	2.695M
December 31, 2022	1.880M
September 30, 2022	2.840M
June 30, 2022	2.833M
March 31, 2022	3.029M
December 31, 2021	2.631M
September 30, 2021	3.005M
June 30, 2021	3.442M
March 31, 2021	4.249M
December 31, 2020	3.748M
September 30, 2020	3.452M
June 30, 2020	5.900M
March 31, 2020	4.189M
December 31, 2019	3.843M
September 30, 2019	4.608M
June 30, 2019	4.584M
March 31, 2019	4.706M
December 31, 2018	4.620M
September 30, 2018	4.055M

Date	Value
June 30, 2018	3.872M
March 31, 2018	4.294M
December 31, 2017	2.992M
September 30, 2017	2.451M
June 30, 2017	2.601M
March 31, 2017	2.871M
December 31, 2016	2.739M
September 30, 2016	2.380M
June 30, 2016	2.250M
March 31, 2016	2.382M
December 31, 2015	1.935M
September 30, 2015	1.876M
June 30, 2015	1.848M
March 31, 2015	1.917M
December 31, 2014	4.477M
September 30, 2014	2.414M
June 30, 2014	3.095M
March 31, 2014	2.037M
December 31, 2013	1.878M
September 30, 2013	0.2918M
June 30, 2013	0.1289M
March 31, 2013	0.1674M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.880M

Minimum

Dec 2022

5.900M

Maximum

Jun 2020

3.402M

Average

3.029M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks